IL6 and Alzheimer disease: During the last decade, IL-6 has been identified as a biomarker for several neuroinflammatory diseases, including depression and Alzheimer’s disease (Miller et al., 2009; Calsolaro and Edison, 2016; Lyra et al., 2021).